PODCAST: The FRONTLINE Dispatch

Maria Ressa, Duterte & the Fight for the Free Press

June 12, 2020

Elosia Lopez/REUTERS

Days before an expected verdict in her trial, Philippine journalist Maria Ressa speaks out about reporting on President Rodrigo Duterte’s brutal drug war — and then becoming a high-profile target of his government’s crackdown on the press. 

As she faces potential prison time on cyber libel charges, the co-founder and CEO of the independent Philippine news site Rappler tells FRONTLINE how she’s preparing, discusses her reporting on Duterte, and says that her conviction about what she does is undaunted: “All it has done is to make us stronger in our intent to continue to hold government to account…”

For more on Duterte’s drug war, watch FRONTLINE’s On the President’s Orders. And for more from Ressa, read FRONTLINE’s interview with her for The Facebook Dilemma, in which she discusses her reporting on how Duterte weaponized the platform to target his critics and spread disinformation. Plus: Stay tuned for the forthcoming documentary A Thousand Cutsfeaturing Ressa’s story, which will see a summer theatrical release and a fall FRONTLINE broadcast. 

More Podcasts

Un(re)solved
What prompted the U.S. Department of Justice to investigate over 150 unsolved civil rights era killings? And what does justice look like for the families of the victims? Reporter James Edwards seeks answers to these questions, reflecting on his own family’s experiences along the way.
I’m Not A Monster
Secrets, lies and lasting consequences. For the past four years, journalist Josh Baker has been trying to uncover the truth about an American family’s journey from Indiana to the Islamic State group’s caliphate and back.
FRONTLINE Film Audio Track
FRONTLINE documentaries, in audio form. Stream or download full-length recordings of film audio tracks.

The FRONTLINE Dispatch is made possible by the Abrams Foundation and by the GBH Catalyst Fund. Additional support for The FRONTLINE Dispatch comes from the Massachusetts General Hospital Cancer Center.